SORBS2
Basic information
Region (hg38): 4:185585444-185956652
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SORBS2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 97 | 104 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 97 | 8 | 4 |
Variants in SORBS2
This is a list of pathogenic ClinVar variants found in the SORBS2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-185587654-G-T | not specified | Uncertain significance (Oct 26, 2021) | ||
4-185587666-G-T | not specified | Uncertain significance (Sep 27, 2021) | ||
4-185589687-C-A | not specified | Uncertain significance (Mar 20, 2024) | ||
4-185589691-C-T | not specified | Uncertain significance (Nov 23, 2024) | ||
4-185593893-C-G | not specified | Uncertain significance (May 17, 2023) | ||
4-185593896-C-A | not specified | Uncertain significance (Mar 31, 2023) | ||
4-185593899-C-T | not specified | Uncertain significance (Mar 20, 2024) | ||
4-185611819-G-C | not specified | Uncertain significance (Aug 12, 2021) | ||
4-185611827-G-T | not specified | Uncertain significance (Jun 03, 2022) | ||
4-185611836-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
4-185611842-G-T | not specified | Uncertain significance (Oct 01, 2024) | ||
4-185611875-C-T | not specified | Likely benign (Apr 19, 2023) | ||
4-185611935-C-G | not specified | Uncertain significance (Nov 09, 2024) | ||
4-185611965-G-T | not specified | Uncertain significance (Dec 03, 2021) | ||
4-185614884-T-C | not specified | Uncertain significance (May 16, 2024) | ||
4-185614902-C-T | not specified | Uncertain significance (Sep 09, 2024) | ||
4-185614952-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
4-185615050-C-T | not specified | Uncertain significance (Jun 13, 2022) | ||
4-185615058-A-T | not specified | Uncertain significance (Apr 20, 2024) | ||
4-185615076-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
4-185615094-T-A | not specified | Uncertain significance (May 30, 2023) | ||
4-185615127-T-A | not specified | Uncertain significance (Sep 26, 2024) | ||
4-185620086-T-C | not specified | Uncertain significance (Feb 16, 2023) | ||
4-185620095-G-C | not specified | Uncertain significance (Jan 03, 2024) | ||
4-185620107-C-A | not specified | Uncertain significance (Apr 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SORBS2 | protein_coding | protein_coding | ENST00000355634 | 21 | 371209 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0359 | 0.964 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.108 | 687 | 695 | 0.989 | 0.0000427 | 7898 |
Missense in Polyphen | 278 | 313.15 | 0.88776 | 3653 | ||
Synonymous | -0.799 | 291 | 274 | 1.06 | 0.0000191 | 2303 |
Loss of Function | 5.08 | 14 | 54.5 | 0.257 | 0.00000297 | 669 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000152 | 0.000149 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.000104 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Adapter protein that plays a role in the assembling of signaling complexes, being a link between ABL kinases and actin cytoskeleton. Can form complex with ABL1 and CBL, thus promoting ubiquitination and degradation of ABL1 or with AKT1 and PAK1, thus mediating AKT1-mediated activation of PAK1. May play a role in the regulation of pancreatic cell adhesion, possibly by acting on WASF1 phosphorylation, enhancing phosphorylation by ABL1, as well as dephosphorylation by PTPN12 (PubMed:18559503). Isoform 6 increases water and sodium absorption in the intestine and gall- bladder. {ECO:0000269|PubMed:12475393, ECO:0000269|PubMed:18559503, ECO:0000269|PubMed:9211900}.;
Recessive Scores
- pRec
- 0.137
Intolerance Scores
- loftool
- 0.717
- rvis_EVS
- -0.52
- rvis_percentile_EVS
- 20.95
Haploinsufficiency Scores
- pHI
- 0.408
- hipred
- Y
- hipred_score
- 0.637
- ghis
- 0.515
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.912
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sorbs2
- Phenotype
- homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; pigmentation phenotype;
Gene ontology
- Biological process
- actin filament organization;Notch signaling pathway;biological_process;cell growth involved in cardiac muscle cell development
- Cellular component
- nucleus;nucleoplasm;plasma membrane;focal adhesion;actin cytoskeleton;apical plasma membrane;Z disc;lamellipodium;perinuclear region of cytoplasm
- Molecular function
- RNA binding;structural constituent of cytoskeleton;protein binding;cytoskeletal adaptor activity;structural constituent of muscle